Prakt. lékáren. 2013; 9(6): 240-242

Correct dosage of paracetamol; analgesic efficacy of paracetamol in combination with caffeine

Lenka Součková
Anesteziologicko-resuscitační klinika, FN u sv. Anny v Brně

Paracetamol is currently among the most widely used analgesics worldwide. Many years of experience with the use of paracetamol have

shown its excellent tolerability and efficacy in therapeutic doses, which are the main reasons for its frequent prescription and usage

both in patients in infancy and toddlerhood and in children of preschool and school age, as well as in adult and geriatric patients, but

also pregnant and breast-feeding patients. In a number of countries, paracetamol is among over-the-counter drugs and thus ranks first

in the consumption of analgesic-antipyretic drugs in many cases.

With the increasing use of paracetamol, however, there are increasing cases of severe liver damage associated with its overdose. On the

other hand, in individuals with a body weight over 50 kg, underdosage occurs with the use of one 500 mg paracetamol tablet, which may

result in reduced analgesic efficacy. Physicians and pharmacists should emphasise the need for patients to administer a correct dose in

order to achieve the desired analgesic effect. The dosage should be defined based on the patient’s body weight. The generally stated

single analgesic dose of paracetamol by mouth is 10 mg/kg to 15 mg/kg.

Keywords: paracetamol, dosage, caffeine, hepatotoxicity

Published: December 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Součková L. Correct dosage of paracetamol; analgesic efficacy of paracetamol in combination with caffeine. Praktické lékárenství. 2013;9(6):240-242.
Download citation

References

  1. Graham GG, Scott KF, Day RO. Tolerability of Paracetamol. Drug Safety. 2006; 28(3): 227-240. Go to original source... Go to PubMed...
  2. Dart RC, Erdman AR, Olson KR, et al. Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2006; 44: 1-18. Go to original source... Go to PubMed...
  3. Linden CH, Rumack BH. Acetaminophen overdose. Emerg Med Clin North Am. 1984; 2: 103-119. Go to original source...
  4. Kršiak M. Optimální dávkování paracetamolu při léčbě bolesti a horečky, Pediatrie pro praxi 2010; 11(1): 21-23.
  5. Makin AJ, Wendon J, williams R. A 7-year experience of severe acetaminophen-induced hepattoxicity (1987-1993). Gastroenterology 1995; 109: 1907-1916. Go to original source... Go to PubMed...
  6. Hladík M. Akutní poškození jater paracetamolem. Pediatrie pro praxi 2005; 4: 212-214.
  7. Daly FFS, Fountain JS, Murray L, Graudins A, Buckley NA. Guidelines for the management of paracetamol poisoning in Australia and New Zealand-explanation and elaboration. Med J Aust. 2008; 188(5): 296-302. Go to original source... Go to PubMed...
  8. Straube A, Aicher B, Fiebich BL, Haag G. Combined analgetik in (headache) pain therapy: shotgun approach or precise multitarget therapuetics? BMC Neurology 2011; 43: 11. Go to original source... Go to PubMed...
  9. Kršiak M. Žádoucí interakce analgetik, Praktické lékárenství. 2006; 1: 15-17.
  10. Laska EM, Sunshine A, Mueller F, et al. Caffeine as an analgesic adjutant. JAMA. 1984; 251(13): 1711-1718. Go to original source...
  11. Renner B, Clarke G, Grattan T, Beisel A, Mueller C, Werner U, Kobal G, Brune K. Caffeine accelerates absorption and enhances the analgetsic effect of acetaminophen. J Clin Phramacol. 2007; (47): 715-726. Go to original source... Go to PubMed...
  12. Migliardi JR, Armellino JJ, Friedman M, Gillings DB, Beaver WT. Caffeine as an analgesic adjutant in tension headache. Clin Pharmacol Ther. 1994; 56: 576-586. Go to original source... Go to PubMed...
  13. Ali Z, Burnett I, Eccles R, North M, Jawad M, Jawad S, Clarke G, Milsom I. Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea. Cur Med Res Opinion. 2001; 23: 841-851. Go to original source... Go to PubMed...
  14. Micromedex 2012.




Pharmacy for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.